Bicycle Therapeutics plc
News
Bicycle Therapeutics (NASDAQ:BCYC) Rating Reiterated by Cantor Fitzgerald
Ticker Report Bicycle Therapeutics (NASDAQ:BCYC - Get Free Report)s stock had its "overweight" rating reissued by investment analysts at Cantor Fitzgerald in a report issued on Monday, Benzinga reports...\n more…
Bicycle Therapeutics (NASDAQ:BCYC) Earns Buy Rating from Needham & Company LLC
Ticker Report Needham Company LLC reissued their buy rating on shares of Bicycle Therapeutics (NASDAQ:BCYC - Free Report) in a report issued on Monday morning, Benzinga reports. Needham Company LLC...\n more…
Oppenheimer Keeps Their Buy Rating on Bicycle Therapeutics (BCYC)
TipRanks Financial Blog In a report released today, Jay Olson from Oppenheimer maintained a Buy rating on Bicycle Therapeutics (BCYC - Research Report), with a price targe...\n more…
Barclays Issues a Buy Rating on Bicycle Therapeutics (BCYC)
TipRanks Financial Blog In a report released today, Peter Lawson from Barclays assigned a Buy rating to Bicycle Therapeutics (BCYC - Research Report), with a price target ...\n more…
Candriam S.C.A. Reduces Stake in Bicycle Therapeutics plc (NASDAQ:BCYC)
Ticker Report Candriam S.C.A. lessened its stake in Bicycle Therapeutics plc (NASDAQ:BCYC - Free Report) by 14.6% during the 2nd quarter, HoldingsChannel reports. The firm owned 759,180 shares of the company's...\n more…
Bicycle Therapeutics (NASDAQ:BCYC) Now Covered by Analysts at Royal Bank of Canada
Ticker Report Royal Bank of Canada assumed coverage on shares of Bicycle Therapeutics (NASDAQ:BCYC - Free Report) in a research report report published on Friday morning, MarketBeat reports. The firm issued an...\n more…